We're doing lots of pre-clinical work. IPIX is not
Post# of 72440
K reformulation (oral).
B-UP formulation optimization (foam?).
B-OM formulation optimization (sachets, foam, gel, etc.).
B for topical applications (preclinical testing + formulation)
Aside from the P results though, I believe you are correct that a significant business development will be the next catalyst.